Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 2, 1999, Pages 120-125

  Pedraza, María Antonia ^a   Del Romero, Jorge ^b   Roldán, Fernando ^b   García, Soledad ^b   Ayerbe, María Cruz ^c   Noriega, Antonio R ^a   Alcamí, José ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO SANITARIO SANDOVAL   (Spain)

^c Dir de Atención Primaria ^*  (Spain)

Author keywords

CCR5; Heterosexual transmission; HIV isolation; Viral load

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE DELETION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; VIRUS CULTURE; VIRUS ISOLATION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; COHORT STUDIES; COITUS; FEMALE; GENOTYPE; HETEROSEXUALITY; HIV INFECTIONS; HIV-1; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, CCR5; RISK FACTORS; SEQUENCE DELETION; SEXUAL PARTNERS; TIME FACTORS; VIRAL LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MARTES PENNANTI; RNA VIRUSES;

EID: 0033152316     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hankins C. Sexual transmission of HIV to women in industrial countries. World Health Stat Q 1996;49:106-14.
2. Mayer KH, Anderson DJ. Heterosexual transmission. Infect Agents Dis 1995;4:273-84.
3. Royce RA, Seña A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
4. Downs AM, De Vincenzi I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. European Study Group in Heterosexual transmission of HIV. J Acquir Defic Syndr Hum Retrovirol 1996;11:388-95.
5. Clerici M, Giorgi JV, Chou Ch, et al. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992;165:1012-19.
6. Rowland-Jones S, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995;1:59-64.
7. Paxton WA, Martin SR, Tse D, et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiply high-risk sexual exposures. Nat Med 1996; 2:412-17.
8. Mazzoli S, Trabattoni D, Lo Caputo S, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-7.
9. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-77.
10. Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR5 Δ-32 deletion heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS 1997;11:73-8.
11. Soto-Ramírez LE, Renjifo B, McLane MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-3.
12. Leg T, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:427-8.
13. Fiore JR, Zhang Y, Björndal A, et al. Biological correlates of HIV-1 heterosexual transmission. AIDS 1997;11:1089-94.
14. Ragni M, Faruki H, Kingsley L. Heterosexual HIV-1 transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:42-5.
15. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
16. Mulder J, Mckinney N, Christopherson C, et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
17. Hammer S, Grumpacker C, D'Aquila R, et al. Use of virological assay for detection of Human Immunodeficiency Virus in clinical trials: recommendations of AIDS Clinical Trials Group Virology committee. J Clin Microbiol 1993;31:2557-66.
18. Fenyö EM, Albert J, Asjö B. Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 1989;3:S5-12.
19. Cao Y, Qin L, Ho D. Virologic and immunologic characterization of long-term survivors of HIV type 1 infection. N Engl J Med 1995;332:201-8.
20. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS 1997;11:1249-54.
21. Carré N, Meyer L, Boufassa F, et al. High risk of HIV disease progression after infection through a sexual partner with AIDS. AIDS 1996;10:77-80.
22. Mellors JW, Rinaldo CR, Grupta P, et al. Prognosis of HIV infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
23. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med 1996;335:1091-8.
24. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 1993;197:624-9.
25. Fenyö EM, Fiore JR, Karlsson A, Albert J, Scarlatti G. Biological phenotypes of HIV-1 in pathogenesis and transmission. Antibiot Chemother 1994;46:18-24.